Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s share price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $4.42 and traded as high as $4.47. Evotec shares last traded at $4.42, with a volume of 44,607 shares trading hands.
Evotec Price Performance
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The business has a fifty day simple moving average of $4.42 and a 200-day simple moving average of $4.16. The stock has a market capitalization of $1.46 billion, a P/E ratio of 10.78 and a beta of 0.98.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
- Five stocks we like better than Evotec
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Monster Growth Stocks to Buy Now
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Investing in the High PE Growth Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.